AKIN GUMP STRAUSS HAUER & FELD

Lobbying for BIOSPLICE THERAPEUTICS, INC. · Pharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $70,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Health Issues

Issues related to the development of therapies for osteoarthritis and areas of significant unmet medical need; Issues related to appropriations report language for Fiscal Year 2027.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.